Taiho and Nippon Shinyaku end Japan alliance for pruritus agent
This article was originally published in Scrip
Executive Summary
The Otsuka subsidiary Taiho Pharmaceutical and Nippon Shinyaku have terminated a licensing agreement for a topically applied anti-itching agent.